Kailera Therapeutics, Inc (KLRA) insider trading
Every open-market stock purchase and sale by Kailera Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $327M over the last 12 months (5 buys).
- Last insider buy: Bain Capital Investors LLC (Insider), $134M, 5 months ago.
Last 12 months: insiders bought $327M (5 buys) and sold $0 (0 sales).
Recent KLRA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | Ronald C Renaud JR (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Bain Capital Investors LLC (Insider) | Bought | $134M |
| Apr 20, 2026 | Andrew T. Kaplan (Insider) | Bought | $134M |
| Apr 20, 2026 | Adam Koppel (Insider) | Bought | $25M |
| Apr 20, 2026 | Bain Capital Life Sciences Investors LLC (Insider) | Bought | $25M |
| Apr 20, 2026 | Rtw Investments LP (Insider) | Bought | $8M |
| Apr 20, 2026 | Adam Koppel (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Adam Koppel (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Bain Capital Investors LLC (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Bain Capital Life Sciences Investors LLC (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Bain Capital Life Sciences Investors LLC (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Andrew T. Kaplan (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. (10% owner) | Bought (not open market) | — |
| Apr 20, 2026 | Rtw Investments LP (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Rtw Investments LP (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Rtw Investments LP (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Scott Akamine (C-suite exec) | Bought (not open market) | — |
| Apr 16, 2026 | Frank Clyburn (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Andrew T. Kaplan (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Paula Cloghessy (C-suite exec) | Bought (not open market) | — |
| Apr 16, 2026 | Adam Koppel (Insider) | Bought (not open market) | — |
| Apr 16, 2026 | Jamie Beth Coleman (C-suite exec) | Bought (not open market) | — |
Who's trading KLRA
- Ronald C Renaud JR, CEO: other filings, last Jun 9, 2026
- Bain Capital Life Sciences Investors LLC, Insider: bought $25M (1 buy), last Apr 20, 2026
- Bain Capital Investors LLC, Insider: bought $134M (1 buy), last Apr 20, 2026
- Adam Koppel, Insider: bought $25M (1 buy), last Apr 20, 2026
- Rtw Investments LP, Insider: bought $8M (1 buy), last Apr 20, 2026
- Andrew T. Kaplan, Insider: bought $134M (1 buy), last Apr 20, 2026
- Jiangsu Hengrui Pharmaceuticals Co. Ltd., 10% owner: other filings, last Apr 20, 2026
- John F Milligan, Insider: other filings, last Apr 16, 2026
- Douglas W. Pagan, CFO: other filings, last Apr 16, 2026
- Scott Akamine, C-suite exec: other filings, last Apr 16, 2026
- Scott M. Wasserman, C-suite exec: other filings, last Apr 16, 2026
- Paul D. Burgess, Insider: other filings, last Apr 16, 2026
- Paula Cloghessy, C-suite exec: other filings, last Apr 16, 2026
- Frank Clyburn, Insider: other filings, last Apr 16, 2026
- Jamie Beth Coleman, C-suite exec: other filings, last Apr 16, 2026
Get free alerts when an insider at Kailera Therapeutics, Inc files a new trade →